文献速递消化道肿瘤与早癌消化内镜

结肠镜阴性后行粪便免疫化学检测可降低人群筛查项目中的结直肠癌发病风险

Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.
PubMed 文献 · Gut · 2020-09-28

本研究基于台湾结直肠癌筛查项目2004-2009年首次筛查中粪便免疫化学检测(FIT)阳性且结肠镜阴性者9179例,随访至2014年底。其中6195例接受后续FIT筛查,其结直肠癌发病率(每1000人年1.34)低于未接受后续FIT者(2.69),调整后HR为0.47(95%CI 0.31-0.71)。作者结论认为结肠镜阴性后应安排后续FIT以检出漏诊肿瘤并降低结直肠癌发病风险。

要点

  • FIT阳性且结肠镜阴性者9179例中,6195例接受后续FIT筛查。
  • 接受后续FIT者结直肠癌发病率每1000人年1.34,未接受者为2.69,调整后HR为0.47(95%CI 0.31-0.71)。
  • 作者结论认为结肠镜阴性后应安排后续FIT以检出漏诊肿瘤并降低结直肠癌发病风险。

核心结论

  • 作者结论认为结肠镜阴性后应安排后续FIT以检出漏诊肿瘤并降低结直肠癌发病风险。

研究设计与样本

  • 基于台湾结直肠癌筛查项目2004-2009年首次筛查中FIT阳性且结肠镜阴性者9179例,随访至2014年底。
  • 比较接受与未接受后续FIT筛查者的结直肠癌发病率,采用Cox回归分析调整主要混杂因素。

主要发现

  • 9179例中6195例在研究期间接受了后续FIT筛查。
  • 接受后续FIT者结直肠癌发病率为每1000人年1.34,未接受者为2.69,调整后HR为0.47(95%CI 0.31-0.71)。
  • 诊断性结肠镜腺瘤检出率较低与结直肠癌发病风险较高相关,但调整后续FIT后多变量分析中不再显著。
  • 基线粪便血红蛋白浓度(FHbC,μg血红蛋白/g粪便)较高与结直肠癌发病风险增加相关:以FHbC=20-39为参照,FHbC=40-59的aHR=1.93(95%CI 1.04-3.56),60-99的aHR=0.95(95%CI 0.45-2.00),100-149的aHR=2.26(95%CI 1.16-4.43),≥150的aHR=2.44(95%CI 1.44-4.12)。

临床怎么用

  • 作者结论认为结肠镜阴性后应安排后续FIT以检出漏诊肿瘤并降低结直肠癌发病风险。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Subjects with a positive faecal immunochemical test (FIT) have a much higher likelihood of advanced neoplasms than the general population. Whether FIT-positive subjects with negative colonoscopy should receive subsequent FIT screening remain unclear. DESIGN: Subjects with a negative colonoscopy after positive FIT in the first screening in the Taiwanese Colorectal Cancer (CRC) Screening Program 2004-2009 were followed until the end of 2014. CRC incidence was compared between those who did and did not receive subsequent FIT screening. Cox regression analysis was conducted, adjusting for major confounders to investigate whether subsequent FIT was associated with lower risk of incident CRC. RESULTS: The study cohort was comprised of 9179 subjects who had negative diagnostic colonoscopy after positive FIT in 2004-2009, of whom 6195 received subsequent FIT during the study period. The CRC incidence (per 1000 person years) was 1.34 in those who received subsequent FIT and 2.69 in those who did not, with corresponding adjusted HR (aHR) of 0.47 (95% CI 0.31 to 0.71). Lower adenoma detection rate of diagnostic colonoscopy was associated with higher risk of incident CRC but became non-significant in multivariable analysis after adjustment for subsequent FIT. Higher baseline faecal haemoglobin concentration (FHbC, μg haemoglobin/g faeces) was associated with increased risk of incident CRC (reference: FHbC=20-39; aHR=1.93 (1.04-3.56), 0.95 (0.45-2.00), 2.26 (1.16-4.43) and 2.44 (1.44-4.12) for FHbC=40-59, 60-99, 100-149 and ≥150, respectively). CONCLUSION: Subsequent FIT should be scheduled after negative colonoscopy to detect missed neoplasms and reduce the risk of incident CRC in a national FIT screening programme.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Peng SM, Hsu WF, Wang YW, et al. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme. Gut. 2020. PMID: 32989019. doi:10.1136/gutjnl-2020-320761

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。